Benefits of a pediatric antimicrobial stewardship program at a children's hospital

M Cecilia Di Pentima1, Shannon Chan, Jobayer Hossain

  • 1Department of Pediatrics, Vanderbilt University, Nashville, TN 37232-2581, USA. cecilia.dipentima@vanderbilt.edu

Pediatrics
|November 23, 2011
PubMed

Insights

A comprehensive antimicrobial stewardship program significantly reduced antimicrobial use in a pediatric hospital. This initiative improved care quality and prevented antimicrobial resistance without negatively impacting patient outcomes.

Area of Science:

  • Infectious Diseases
  • Hospital Pharmacy
  • Public Health

Background:

  • Antimicrobial resistance is a growing global health threat.
  • Effective antimicrobial stewardship programs are crucial for optimizing antimicrobial use in healthcare settings.

Purpose of the Study:

  • To evaluate the impact of a comprehensive antimicrobial stewardship program on antimicrobial consumption, clinical interventions, patient outcomes, and antimicrobial resistance rates.
  • To assess the effectiveness of active surveillance, provider feedback, and prior authorization in a pediatric teaching hospital.

Main Methods:

  • Implementation of active surveillance for antimicrobial use with real-time provider feedback and prior authorization for specific agents.
  • Mandatory inclusion of antimicrobial-use indications in the electronic health record.
  • Automated generation and review of antimicrobial prescribing data by infectious disease specialists.

Main Results:

  • Total antimicrobial use decreased from 3089 to 1904 doses per 1000 patient-days.
  • Targeted and nontargeted antimicrobial use showed significant reductions.
  • Rates of resistance to broad-spectrum antimicrobials remained low and stable.

Conclusions:

  • Successful implementation of antimicrobial stewardship strategies led to substantial reductions in both targeted and nontargeted antimicrobial prescribing.
  • The program enhanced the quality of care for hospitalized children.
  • The stewardship program was effective in preventing the emergence of antimicrobial resistance.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...